RxDoctor Payments Data

Todd Chappell, DPM

Podiatrist · Tacoma, WANPI 1548675192

Payments from drug & device makers

What this record shows

This record is dominated by education: $6,514 of the $9,267 with a category attached, or 70.3%. 15 manufacturers reported payments, led by Arthrex at 40.6% of the total. Reporting peaked in 2019 at $3,798 and has fallen 87.8% since, to $463 in 2025. Among podiatrist clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,267in general payments, 2019–2025

Across 37 payments — averaging $250.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$4K
  • Summit Surgical Corp.$4K
  • Paragon 28, Inc.$788
  • Zimmer Biomet$266
  • Bioventus LLC$157
  • Acera Surgical, Inc.$152
  • plus $439 from 9 others

What the payments were for

  • Travel & lodging$1,21213%
  • Food & beverage$1,54117%
  • Education$6,51470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,267 in reported general payments places this provider in the 90th percentile of 134 podiatrist providers in Washington.

See all podiatrist providers in Washington

Medicare billing

Part B allowed, 2024
$53,628
Medicare patients
170
Services billed
652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen38$385
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen46$288
Cefdinir18$238
Gabapentin14$167
Ondansetron Hcl28$150

Paid to pharmacies, not to this prescriber.

Other podiatrist in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →